Cystadenoma
Cystadenoma, Mucinous
Cystadenoma, Serous
Cystadenocarcinoma
Mucocele
Biliary Tract Neoplasms
Cysts
Sertoli-Leydig Cell Tumor
Bile Ducts, Intrahepatic
Pancreatic Neoplasms
Adenolymphoma
Cystadenocarcinoma, Mucinous
Hepatic Duct, Common
Spermatocele
Ovarian Neoplasms
Aspermia
Pseudomyxoma Peritonei
Pancreatic Cyst
Neoplasms, Multiple Primary
Retroperitoneal Neoplasms
Salivary Glands, Minor
Tomography, X-Ray Computed
Pancreatic Pseudocyst
Cholangiopancreatography, Magnetic Resonance
Bile Ducts, Extrahepatic
Cystadenocarcinoma, Serous
Overexpression of H-Ryk in mouse fibroblasts confers transforming ability in vitro and in vivo: correlation with up-regulation in epithelial ovarian cancer. (1/109)
Abnormalities in the function of receptor tyrosine kinases (RTKs) have been demonstrated to be important in the pathogenesis of cancer. H-Ryk, a new member of the RTK family, is an unusual RTK in that it is catalytically inactive because of amino acid substitutions of conserved residues in the catalytic domain. We show by immunohistochemistry that it is expressed in the epithelium, stroma, and blood vessels of normal tissues. Evaluation of a panel of 33 primary ovarian tumors (2 benign, 8 borderline, and 23 malignant) was performed. H-Ryk was overexpressed in borderline and malignant ovarian tumors. In serous and clear cell subtypes, there was increased expression in the epithelium, stroma, and blood vessels. Consistent with this observation, overexpression of H-Ryk in the mouse fibroblast cell line NIH3T3 induces anchorage-independent growth and tumorigenicity in nude mice. This implies that overexpression of the receptor can be transforming and may therefore be significant in the pathogenesis of ovarian cancer. (+info)Three dimensional ultrasound and power doppler in assessment of uterine and ovarian angiogenesis: a prospective study. (2/109)
AIM: To determine whether three-dimensional power Doppler can improve the recognition of pelvic tumor morphology and angiogenesis. METHODS: Using this technique we analyzed 180 adnexal masses and 110 uterine lesions. Tumor volume, morphology, and vascularity were evaluated in each patient. Irregular and randomly dispersed vessels with complex branching depicted by comprehensive three dimensional display were suggestive of pelvic malignancy, while linear-like vascular morphology, single vessel arrangement and regular branching were typical for benign structures. RESULTS: Addition of qualitative analysis of vascular architecture of adnexal tumor to morphological parameters reached 96.15% sensitivity and 98.73% specificity. When endometrial lesions were prospectively analyzed, sensitivity and specificity were 91.67% and 98.49%, respectively. Because the lowest positive predictive value of 16.67% was obtained for myometrial lesions, this method should not be advised for their eva luation. CONCLUSION: Good results achieved by three dimensional ultrasound can be explained by improved recognition of the pelvic lesion anatomy, characterization of the surface features, detection of the tumor infiltration, and precise depiction of the size and volume. Three dimensional power Doppler imaging can detect structural abnormalities of the malignant tumor vessels, such as arteriovenous shunts, microaneurysms, tumoral lakes, disproportional calibration, coiling, and dichotomous branching. Therefore it enhances and facilitates the morphologic and functional evaluation of both benign and malignant pelvic tumors. (+info)Clinical significance of magnetic resonance cholangiopancreatography for the diagnosis of cystic tumor of the pancreas compared with endoscopic retrograde cholangiopancreatography and computed tomography. (3/109)
BACKGROUND: Cystic tumor of the pancreas has been investigated by a variety of imaging techniques. Magnetic resonance cholangiopancreatography (MRCP) is being widely used as a non-invasive diagnostic modality for investigation of the biliary tree and pancreatic duct system. The purpose of this study was to compare MRCP images with those of endoscopic retrograde cholangiopancreatography (ERCP) and computed tomography (CT) in order to clarify the diagnostic efficacy of MRCP for cystic tumor of the pancreas. METHODS: We retrospectively studied 15 patients with cystic tumor of the pancreas that had been surgically resected and histopathologically confirmed. There were five cases of intraductal papillary adenocarcinoma, five of intraductal papillary adenoma, two of serous cyst adenoma, two of retention cyst associated with invasive ductal adenocarcinoma and one of solid cystic tumor. RESULTS: In all cases MRCP correctly identified the main pancreatic duct (MPD) and showed the entire cystic tumor and the communication between the tumor and the MPD. On the other hand, the detection rate by ERCP of the cystic tumor and the communication between the cystic tumor and the MPD was only 60%. Although the detection rates by CT for the septum and solid components inside the cystic tumor were 100 and 90.0%, respectively, those of MRCP for each were 58.3 and 20.0%. CONCLUSION: MRCP is capable of providing diagnostic information superior to ERCP for the diagnosis of cystic tumor of the pancreas. Although MRCP may provide complementary information about the whole lesion of interest, the characteristic internal features of cystic tumor of the pancrease should be carefully diagnosed in combination with CT. (+info)Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. (4/109)
OBJECTIVE: To review the features of patients with benign and malignant cystadenomas of the pancreas, focusing on preoperative diagnostic accuracy and long-term outcome, especially for nonoperated serous cystadenomas and resected cystadenocarcinomas. SUMMARY BACKGROUND DATA: Serous cystadenomas (SCAs) are benign tumors. Mucinous cystic neoplasms should be resected because of the risk of malignant progression. A correct preoperative diagnosis of tumor type is based on morphologic criteria. Despite the high quality of recent imaging procedures, the diagnosis frequently remains uncertain. Invasive investigations such as endosonography and diagnostic aspiration of cystic fluid may be helpful, but their assessment is limited to small series. The management of typical SCA may require resection or observation. Survival after pancreatic resection seems better for cystadenocarcinomas (MCACs) than for ductal adenocarcinomas of the pancreas. METHODS: Three hundred ninety-eight cases of cystadenomas of the pancreas were collected between 1984 and 1996 in 73 institutions of the French Surgical Association. Clinical presentation, radiologic evaluation, and surgical procedures were analyzed for 144 operated SCAs, 150 mucinous cystadenomas (MCAs), and 78 MCACs. The outcome of 372 operated patients and 26 nonoperated patients with SCA was analyzed. RESULTS: Cystadenomas represented 76% of all primary pancreatic cystic tumors (398/522). An asymptomatic tumor was discovered in 32% of patients with SCA, 26% of those with MCA, and 13% of those with MCAC. The tumor was located in the head or uncinate process of the pancreas in 38% of those with SCA, 27% of those with MCA, and 49% of those with MCAC. A communication between the cyst and pancreatic duct was discovered in 0.6% of those with SCA, 6% of those with MCA, and 10% of those with MCAC. The main investigations were ultrasonography and computed tomography (94% for SCA, MCA, and MCAC), endosonography (34%, 28%, and 22% for SCA, MCA, and MCAC respectively), endoscopic retrograde cholangiopancreatography (16%, 14%, 22%), and cyst fluid analysis (22%, 31%, 35%). An accurate preoperative diagnosis of tumor type was proposed for 20% of those with SCA (144 cases), 30% of those with MCA, and 29% of those with MCAC. An atypical unilocular macrocyst was observed in 10% of SCA cases. The most common misdiagnosis for mucinous cystic tumors was pseudocyst (9% of MCAs, 15% of MCACs). Intraoperative frozen sections (126 cases) allowed a diagnosis according to definitive histologic examination in 50% of those with SCA and MCA and 62% of those with MCAC. For management, 93% of patients underwent surgery. Nonoperated patients (7%) had exclusively typical SCA. A complete cyst excision was performed in 94% of benign cystadenomas, with an operative mortality rate of 2% for SCA and 1.4% for MCA. Resection was possible in 74% of cases of MCAC. Mean follow-up of 26 patients with nonresected SCAs was 38 months, and no patients required surgery. For resected MCACs, the actuarial 5-year survival rate was 63%. CONCLUSIONS: Spiral computed tomography is the examination of choice for a correct prediction of tumor type. Endosonography may be useful to detect the morphologic criteria of small tumors. Diagnostic aspiration of the cyst allows differentiation of the macrocystic form of SCA (10% of cases) and the unilocular type of mucinous cystic neoplasm from a pseudocyst. Surgical resection should be performed for symptomatic SCAs, all mucinous cystic neoplasms, and cystic tumors that are not clearly defined. Conservative management is wholly justified for a well-documented SCA with no symptoms. An extensive resection is warranted for MCAC because the 5-year survival rate may exceed 60%. (+info)Three-dimensional power Doppler sonography: imaging and quantifying blood flow and vascularization. (5/109)
OBJECTIVES: To assess the feasibility of imaging low-velocity blood flow in adnexal masses by transvaginal three-dimensional power Doppler sonography, to analyze three-dimensional power Doppler sonography data sets with a new computer-assisted method and to test the reproducibility of the technique. METHODS: A commercially available 5-MHz Combison 530 ultrasound system was used to perform three-dimensional power Doppler sonography transvaginally. A cube (= volume of interest) was defined enclosing the vessels of the cyst and the Cartesian characteristics were stored on a hard disk. This cube was analyzed using specially designed software. Five indices representing vascularization (the vascularization index (VI) or blood flow (the flow index (FI)) or both (the vascularization-flow index (VFI)) were calculated. The intraobserver repeatability of cube definition and scan repetition was assessed using Hartley's test for homogeneous variances. Interobserver agreement was assessed by the Pearson correlation coefficient. RESULTS: Imaging of vessels with low-velocity blood flow by three-dimensional power Doppler sonography and cube definition was possible in all adnexal massed studied. In some cases even induced non-vascular flow related to endometriosis was detected. The calculated F value with intraobserver repeated Cartesian file-saving ranged from 0 to 18.8, with intraobserver scan repetition from 4.74 to 24.8 for VI, FI 1, FI 2 and VFI 1; for VFI 2 the calculated F value was 64. The interobserver correlation coefficient ranged between 0.83 and 0.92 for VI, FI 1, FI 2 and VFI 1; for VFI 2 the correlation coefficient was less than 0.75. CONCLUSION: Vessels with low-velocity blood flow can be imaged using three-dimensional power Doppler sonography. Induced non-vascular flow was detected in endometriotic cyst fluid. Three-dimensional power Doppler sonography combined with the cube method gave reproducible information for all indices except VFI 2. These indices might prove to be a new predictor in all fields of neoangiogenesis. The clinical relevance remains to be determined. (+info)Cystic struma ovarii: a rare presentation of an infrequent tumor. (6/109)
CONTEXT: Struma ovarii, a rare neoplasm, is a monophyletic teratoma composed of thyroid tissue. It is generally considered to account for less than 5% of mature teratomas. CASE REPORT: A diagnosis of struma ovarii may be the source of many diagnostic problems. It may be cystic and microscopic examination may only reveal a few typical thyroid follicles, resulting in confusion with other cystic ovarian tumors. Extensive sampling should be undertaken and immunohistochemistry may be decisive in establishing the thyroid nature of the epithelial lining. The authors report two cases of cystic struma ovarii, and discuss diagnostic criteria and the limitations of frozen biopsies in these tumors. (+info)Expression of a homeobox gene (SIX5) in borderline ovarian tumours. (7/109)
AIMS: To assess the expression of SIX5 (a homeobox gene) mRNA in surface coelomic epithelium, endocervical epithelium, Fallopian tube epithelium, and benign, borderline, and malignant epithelial ovarian tumours. METHODS: 10 normal premenopausal ovaries, 10 normal Fallopian tubes, 10 normal cervices, 10 normal postmenopausal ovaries, 10 benign epithelial ovarian tumours, 10 malignant epithelial ovarian tumours, and 40 borderline epithelial ovarian tumours were studied retrospectively. The tissues had been fixed in formalin and embedded in paraffin wax. The tumours had previously been typed into mucinous, serous, or mixed tumours and assigned to the borderline category according to the FIGO/WHO criteria. Expression was assessed by in situ binding of SIX5 specific sense and antisense riboprobes. Hybridization of the riboprobes was detected using a standard immunohistochemical technique and the results correlated with expression in the normal epithelium of the endocervix, Fallopian tube, surface coelomic epithelium, and ovarian tumours. RESULTS: Expression of SIX5 mRNA was demonstrated in normal Fallopian tube epithelium and normal endocervical epithelium. SIX5 mRNA was not detected in normal ovarian epithelial tissue at any of the times studied during the menstrual cycle. Expression of SIX5 was not shown in benign epithelial ovarian tumours or in any of the malignant epithelial ovarian tumours. In 31 of 37 borderline epithelial ovarian tumours (84%), SIX5 expression was found in the epithelial cells. CONCLUSIONS: SIX5 expression is present in the normal epithelium throughout most of the female reproductive tract, suggesting it may have a role in maintaining epithelial differentiation in these tissues. SIX5 expression appears to be restricted to borderline epithelial ovarian tumours and may be a marker of epithelial differentiation in these tumours; thus borderline ovarian tumours may not be part of a continuum of disease between benign and malignant epithelial ovarian tumours. Further investigation of expression of SIX5 may clarify the molecular processes that promote differentiation of the ovarian surface epithelium. (+info)Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins. (8/109)
The high mobility group I (HMGI) family of proteins in mammals belongs to a group of nonhistone nuclear proteins known as architectural transcriptional factors. They function in vivo as both structural components of chromatin and auxiliary gene transcription factors. In an earlier study (N. Abe et al, Cancer Res., 59: 1169-1174, 1999), we demonstrated that the expression level of the HMGI(Y) gene/proteins was significantly increased in colorectal adenocarcinoma and colorectal adenoma with severe cellular atypia. In the current study, we analyzed HMGI(Y) expression in several human pancreatic lesions to investigate (a) whether HMGI(Y) overexpression is also observed in pancreatic carcinoma, and (b) the role of HMGI(Y) in the diagnosis of pancreatic neoplasms. To this end, HMGI(Y) expression was determined at the protein level by immunohistochemistry using a HMGI(Y)-specific antibody in 6 surgically resected specimens of nonneoplastic tissue (4 specimens of normal pancreatic tissue and 2 specimens of chronic pancreatitis tissue), 8 pancreatic cystic neoplasms (5 intraductal papillary mucinous adenomas, 1 serous cystadenoma, and 2 solid pseudopapillary tumors), and 15 duct cell carcinomas of the pancreas. Immunohistochemical analysis revealed intense nuclear staining in the pancreatic carcinoma cells, whereas only very faint nuclear staining was seen in the nonneoplastic cells. There was a strong correlation between HMGI(Y) protein overexpression and a diagnosis of carcinoma (P = 0.000018). Thus, an increased expression level of the HMGI(Y) proteins was clearly associated with the malignant phenotype in pancreatic tissue. In addition, a low level of protein expression was also apparent in two of the cystic neoplasms that exhibited cellular atypia, but not in those that did not exhibit cellular atypia. Based on these findings, we propose that the HMGI(Y) proteins could be closely associated with tumorigenesis in the pancreas and that HMGI(Y) could serve as a potential diagnostic molecular marker for distinguishing pancreatic malignancies unambiguously from normal tissue or benign lesions. (+info)Cystadenoma is a type of benign tumor (not cancerous), which arises from glandular epithelial cells and is covered by a thin layer of connective tissue. These tumors can develop in various locations within the body, including the ovaries, pancreas, and other organs that contain glands.
There are two main types of cystadenomas: serous and mucinous. Serous cystadenomas are filled with a clear or watery fluid, while mucinous cystadenomas contain a thick, gelatinous material. Although they are generally not harmful, these tumors can grow quite large and cause discomfort or other symptoms due to their size or location. In some cases, cystadenomas may undergo malignant transformation and develop into cancerous tumors, known as cystadenocarcinomas. Regular medical follow-up and monitoring are essential for individuals diagnosed with cystadenomas to ensure early detection and treatment of any potential complications.
Mucinous cystadenoma is a type of benign tumor that arises from the epithelial cells lining the mucous membranes of the body. It is most commonly found in the ovary, but can also occur in other locations such as the pancreas or appendix.
Mucinous cystadenomas are characterized by the production of large amounts of mucin, a slippery, gel-like substance that accumulates inside the tumor and causes it to grow into a cystic mass. These tumors can vary in size, ranging from a few centimeters to over 20 centimeters in diameter.
While mucinous cystadenomas are generally benign, they have the potential to become cancerous (mucinous cystadenocarcinoma) if left untreated. Symptoms of mucinous cystadenoma may include abdominal pain or swelling, bloating, and changes in bowel movements or urinary habits. Treatment typically involves surgical removal of the tumor.
A serous cystadenoma is a type of benign tumor that arises from the epithelial cells lining the serous glands, which are glands that produce a watery, lubricating fluid. This type of tumor typically develops in the ovary or the pancreas.
Serous cystadenomas of the ovary are usually filled with a clear, watery fluid and have multiple loculations (compartments). They can vary in size from a few millimeters to several centimeters in diameter. Although these tumors are benign, they can cause symptoms if they become large enough to press on surrounding organs or if they rupture and release their contents into the abdominal cavity.
Serous cystadenomas of the pancreas are less common than ovarian serous cystadenomas. They typically occur in the tail of the pancreas and can range in size from a few millimeters to several centimeters in diameter. These tumors are usually asymptomatic, but they can cause symptoms such as abdominal pain or discomfort if they become large enough to press on surrounding organs.
It is important to note that while serous cystadenomas are generally benign, there is a small risk that they may undergo malignant transformation and develop into a type of cancer known as a serous cystadenocarcinoma. For this reason, it is important for patients with these tumors to be followed closely by a healthcare provider and to have regular imaging studies and/or surgical excision to monitor for any changes in the tumor.
Papillary cystadenoma is a type of benign (non-cancerous) tumor that arises from the glandular cells in various organs. It is characterized by the growth of finger-like projections (papillae) inside the cysts. These tumors can occur in different parts of the body, including the ovaries, pancreas, and the lining of the abdominal cavity (peritoneum).
In general, papillary cystadenomas are slow-growing and do not typically spread to other organs. However, they can cause symptoms such as pain or discomfort if they become large enough to press on surrounding tissues. Treatment usually involves surgical removal of the tumor. It is important to note that while papillary cystadenomas are generally benign, there is a small risk that they may undergo malignant transformation and develop into cancerous tumors over time. Regular follow-up with a healthcare provider is recommended to monitor for any changes in the tumor or the development of new symptoms.
Cystadenocarcinoma is a type of tumor that arises from the epithelial lining of a cyst, and it has the potential to invade surrounding tissues and spread (metastasize) to other parts of the body. It typically affects glandular organs such as the ovaries, pancreas, and salivary glands.
Cystadenocarcinomas can be classified into two types: serous and mucinous. Serous cystadenocarcinomas produce a watery fluid, while mucinous cystadenocarcinomas produce a thick, mucus-like fluid. Both types of tumors can be benign or malignant, but malignant cystadenocarcinomas are more aggressive and have a higher risk of metastasis.
Symptoms of cystadenocarcinoma depend on the location and size of the tumor. In some cases, there may be no symptoms until the tumor has grown large enough to cause pain or other problems. Treatment typically involves surgical removal of the tumor, along with any affected surrounding tissue. Chemotherapy and radiation therapy may also be used in some cases to help prevent recurrence or spread of the cancer.
Appendiceal neoplasms refer to various types of tumors that can develop in the appendix, a small tube-like structure attached to the large intestine. These neoplasms can be benign or malignant and can include:
1. Adenomas: These are benign tumors that arise from the glandular cells lining the appendix. They are usually slow-growing and may not cause any symptoms.
2. Carcinoids: These are neuroendocrine tumors that arise from the hormone-producing cells in the appendix. They are typically small and slow-growing, but some can be aggressive and spread to other parts of the body.
3. Mucinous neoplasms: These are tumors that produce mucin, a slippery substance that can cause the appendix to become distended and filled with mucus. They can be low-grade (less aggressive) or high-grade (more aggressive) and may spread to other parts of the abdomen.
4. Adenocarcinomas: These are malignant tumors that arise from the glandular cells lining the appendix. They are relatively rare but can be aggressive and spread to other parts of the body.
5. Pseudomyxoma peritonei: This is a condition in which mucin produced by an appendiceal neoplasm leaks into the abdominal cavity, causing a jelly-like accumulation of fluid and tissue. It can be caused by both benign and malignant tumors.
Treatment for appendiceal neoplasms depends on the type and stage of the tumor, as well as the patient's overall health. Treatment options may include surgery, chemotherapy, or radiation therapy.
A mucocele is a mucus-containing cystic lesion that results from the accumulation of mucin within a damaged minor salivary gland duct or mucous gland. It is typically caused by trauma, injury, or blockage of the duct. Mucocele appears as a round, dome-shaped, fluid-filled swelling, which may be bluish or clear in color. They are most commonly found on the lower lip but can also occur on other areas of the oral cavity. Mucocele is generally painless unless it becomes secondarily infected; however, it can cause discomfort during speaking, chewing, or swallowing, and may affect aesthetics. Treatment usually involves surgical excision of the mucocele to prevent recurrence.
Biliary tract neoplasms refer to abnormal growths or tumors that develop in the biliary system, which includes the gallbladder, bile ducts inside and outside the liver, and the ducts that connect the liver to the small intestine. These neoplasms can be benign (non-cancerous) or malignant (cancerous).
Malignant biliary tract neoplasms are often referred to as cholangiocarcinoma if they originate in the bile ducts, or gallbladder cancer if they arise in the gallbladder. These cancers are relatively rare but can be aggressive and difficult to treat. They can cause symptoms such as jaundice (yellowing of the skin and eyes), abdominal pain, weight loss, and dark urine.
Risk factors for biliary tract neoplasms include chronic inflammation of the biliary system, primary sclerosing cholangitis, liver cirrhosis, hepatitis B or C infection, parasitic infections, and certain genetic conditions. Early detection and treatment can improve outcomes for patients with these neoplasms.
Bile duct neoplasms, also known as cholangiocarcinomas, refer to a group of malignancies that arise from the bile ducts. These are the tubes that carry bile from the liver to the gallbladder and small intestine. Bile duct neoplasms can be further classified based on their location as intrahepatic (within the liver), perihilar (at the junction of the left and right hepatic ducts), or distal (in the common bile duct).
These tumors are relatively rare, but their incidence has been increasing in recent years. They can cause a variety of symptoms, including jaundice, abdominal pain, weight loss, and fever. The diagnosis of bile duct neoplasms typically involves imaging studies such as CT or MRI scans, as well as blood tests to assess liver function. In some cases, a biopsy may be necessary to confirm the diagnosis.
Treatment options for bile duct neoplasms depend on several factors, including the location and stage of the tumor, as well as the patient's overall health. Surgical resection is the preferred treatment for early-stage tumors, while chemotherapy and radiation therapy may be used in more advanced cases. For patients who are not candidates for surgery, palliative treatments such as stenting or bypass procedures may be recommended to relieve symptoms and improve quality of life.
The appendix is a small, tube-like structure that projects from the large intestine, located in the lower right quadrant of the abdomen. Its function in humans is not well understood and is often considered vestigial, meaning it no longer serves a necessary purpose. However, in some animals, the appendix plays a role in the immune system. Inflammation of the appendix, known as appendicitis, can cause severe abdominal pain and requires medical attention, often leading to surgical removal of the appendix (appendectomy).
Adenoma of the bile duct is a benign (noncancerous) tumor that develops in the bile ducts, which are tiny tubes that carry bile from the liver to the gallbladder and small intestine. Bile is a digestive fluid produced by the liver.
Bile duct adenomas are rare and usually do not cause any symptoms. However, if they grow large enough, they may obstruct the flow of bile and cause jaundice (yellowing of the skin and whites of the eyes), abdominal pain, or itching. In some cases, bile duct adenomas may become cancerous and develop into bile duct carcinomas.
The exact cause of bile duct adenomas is not known, but they are more common in people with certain genetic disorders, such as Gardner's syndrome and von Hippel-Lindau disease. Treatment for bile duct adenomas typically involves surgical removal of the tumor.
A cyst is a closed sac, having a distinct membrane and division between the sac and its surrounding tissue, that contains fluid, air, or semisolid material. Cysts can occur in various parts of the body, including the skin, internal organs, and bones. They can be caused by various factors, such as infection, genetic predisposition, or blockage of a duct or gland. Some cysts may cause symptoms, such as pain or discomfort, while others may not cause any symptoms at all. Treatment for cysts depends on the type and location of the cyst, as well as whether it is causing any problems. Some cysts may go away on their own, while others may need to be drained or removed through a surgical procedure.
A Sertoli-Leydig cell tumor is a rare type of sex cord-stromal tumor that develops in the ovaries. These tumors arise from the cells that produce hormones and help to form and maintain the ovarian tissue. Sertoli-Leydig cell tumors can occur in people of any age but are most commonly found in women between the ages of 20 and 40.
These tumors can be functional, meaning they produce hormones, or nonfunctional. Functional Sertoli-Leydig cell tumors may cause symptoms related to the production of male hormones (androgens), such as excess facial hair, a deepened voice, and irregular menstrual periods. Nonfunctional tumors typically do not cause any specific symptoms and are often found during routine pelvic examinations or imaging studies performed for other reasons.
Sertoli-Leydig cell tumors are usually slow-growing and can vary in size. Most of these tumors are benign (not cancerous), but some can be malignant (cancerous) and may spread to other parts of the body. Treatment typically involves surgical removal of the tumor, and additional therapies such as chemotherapy or radiation therapy may be recommended depending on the stage and grade of the tumor. Regular follow-up care is essential to monitor for any recurrence of the tumor.
Intrahepatic bile ducts are the small tubular structures inside the liver that collect bile from the liver cells (hepatocytes). Bile is a digestive fluid produced by the liver that helps in the absorption of fats and fat-soluble vitamins from food. The intrahepatic bile ducts merge to form larger ducts, which eventually exit the liver and join with the cystic duct from the gallbladder to form the common bile duct. The common bile duct then empties into the duodenum, the first part of the small intestine, where bile aids in digestion. Intrahepatic bile ducts can become obstructed or damaged due to various conditions such as gallstones, tumors, or inflammation, leading to complications like jaundice, liver damage, and infection.
Pancreatic neoplasms refer to abnormal growths in the pancreas that can be benign or malignant. The pancreas is a gland located behind the stomach that produces hormones and digestive enzymes. Pancreatic neoplasms can interfere with the normal functioning of the pancreas, leading to various health complications.
Benign pancreatic neoplasms are non-cancerous growths that do not spread to other parts of the body. They are usually removed through surgery to prevent any potential complications, such as blocking the bile duct or causing pain.
Malignant pancreatic neoplasms, also known as pancreatic cancer, are cancerous growths that can invade and destroy surrounding tissues and organs. They can also spread (metastasize) to other parts of the body, such as the liver, lungs, or bones. Pancreatic cancer is often aggressive and difficult to treat, with a poor prognosis.
There are several types of pancreatic neoplasms, including adenocarcinomas, neuroendocrine tumors, solid pseudopapillary neoplasms, and cystic neoplasms. The specific type of neoplasm is determined through various diagnostic tests, such as imaging studies, biopsies, and blood tests. Treatment options depend on the type, stage, and location of the neoplasm, as well as the patient's overall health and preferences.
Adenolymphoma is a rare, benign tumor that arises from the lymphoid tissue found in glandular structures, such as the salivary glands. It is also known as Warthin's tumor or cystic papillary adenolymphoma.
The tumor is composed of multiple cyst-like spaces lined by columnar epithelial cells and surrounded by lymphoid tissue, which may contain lymphocytes, plasma cells, and occasionally, germinal centers. The etiology of adenolymphoma is unclear, but it has been associated with smoking and genetic factors.
Adenolymphomas are typically slow-growing and painless, although they can cause discomfort or facial asymmetry if they become large enough. They are usually diagnosed through imaging studies such as ultrasound, CT scan, or MRI, followed by a biopsy to confirm the diagnosis.
Treatment of adenolymphoma typically involves surgical excision, which is usually curative. Recurrence after surgery is rare, but long-term follow-up is recommended due to the potential for malignant transformation into squamous cell carcinoma or other malignancies.
Mucinous cystadenocarcinoma is a type of cancer that arises from the mucin-producing cells in the lining of a cyst. It is a subtype of cystadenocarcinoma, which is a malignant tumor that develops within a cyst. Mucinous cystadenocarcinomas are typically found in the ovary or pancreas but can also occur in other organs such as the appendix and the respiratory tract.
These tumors are characterized by the production of large amounts of mucin, a gel-like substance that can accumulate within the cyst and cause it to grow. Mucinous cystadenocarcinomas tend to grow slowly but can become quite large and may eventually spread (metastasize) to other parts of the body if left untreated.
Symptoms of mucinous cystadenocarcinoma depend on the location and size of the tumor, but they may include abdominal pain or discomfort, bloating, changes in bowel movements, or vaginal bleeding. Treatment typically involves surgical removal of the tumor, followed by chemotherapy or radiation therapy to kill any remaining cancer cells. The prognosis for mucinous cystadenocarcinoma depends on several factors, including the stage of the disease at diagnosis and the patient's overall health.
Cecal diseases refer to medical conditions that affect the cecum, which is a pouch-like structure located at the junction of the small and large intestines. The cecum plays an important role in digestion, particularly in the fermentation of certain types of food.
There are several different types of cecal diseases, including:
1. Cecal volvulus: This is a rare condition in which the cecum twists on itself, cutting off blood flow and causing severe pain and other symptoms.
2. Diverticulitis: This occurs when small pouches called diverticula form in the wall of the cecum and become inflamed or infected.
3. Appendicitis: Although not strictly a cecal disease, the appendix is a small tube-like structure that branches off from the cecum. Inflammation of the appendix (appendicitis) can cause severe pain in the lower right abdomen and may require surgical removal of the appendix.
4. Crohn's disease: This is a chronic inflammatory bowel disease that can affect any part of the digestive tract, including the cecum.
5. Tuberculosis: The cecum can also be affected by tuberculosis, which is a bacterial infection that primarily affects the lungs but can spread to other parts of the body.
6. Cancer: Although rare, cancer can also affect the cecum, leading to symptoms such as abdominal pain, bloating, and changes in bowel habits.
Treatment for cecal diseases depends on the specific condition and its severity. Treatment options may include antibiotics, surgery, or other medical interventions. If you are experiencing symptoms that may be related to a cecal disease, it is important to seek medical attention promptly.
The common hepatic duct is a medical term that refers to the duct in the liver responsible for carrying bile from the liver. More specifically, it is the duct that results from the convergence of the right and left hepatic ducts, which themselves carry bile from the right and left lobes of the liver, respectively. The common hepatic duct then joins with the cystic duct from the gallbladder to form the common bile duct, which ultimately drains into the duodenum, a part of the small intestine.
The primary function of the common hepatic duct is to transport bile, a digestive juice produced by the liver, to the small intestine. Bile helps break down fats during the digestion process, making it possible for the body to absorb them properly. Any issues or abnormalities in the common hepatic duct can lead to problems with bile flow and potentially cause health complications such as jaundice, gallstones, or liver damage.
A spermatocele is a type of cyst that develops in the epididymis, which is a small, coiled tube located on the back surface of the testicle. This cyst typically contains sperm and fluid from the epididymis, and it is usually benign and harmless.
Spermatoceles are often asymptomatic and may be discovered during a routine physical examination or self-examination. In some cases, however, they may cause discomfort or pain, particularly if they become large enough to press on the testicle or surrounding structures.
While spermatoceles do not typically require treatment unless they are causing symptoms, it is important to have them evaluated by a healthcare provider to rule out other potential causes of any symptoms and to ensure that appropriate treatment is provided if necessary.
Endocrine gland neoplasms refer to abnormal growths (tumors) that develop in the endocrine glands. These glands are responsible for producing hormones, which are chemical messengers that regulate various functions and processes in the body. Neoplasms can be benign or malignant (cancerous). Benign neoplasms tend to grow slowly and do not spread to other parts of the body. Malignant neoplasms, on the other hand, can invade nearby tissues and organs and may also metastasize (spread) to distant sites.
Endocrine gland neoplasms can occur in any of the endocrine glands, including:
1. Pituitary gland: located at the base of the brain, it produces several hormones that regulate growth and development, as well as other bodily functions.
2. Thyroid gland: located in the neck, it produces thyroid hormones that regulate metabolism and calcium balance.
3. Parathyroid glands: located near the thyroid gland, they produce parathyroid hormone that regulates calcium levels in the blood.
4. Adrenal glands: located on top of each kidney, they produce hormones such as adrenaline, cortisol, and aldosterone that regulate stress response, metabolism, and blood pressure.
5. Pancreas: located behind the stomach, it produces insulin and glucagon, which regulate blood sugar levels, and digestive enzymes that help break down food.
6. Pineal gland: located in the brain, it produces melatonin, a hormone that regulates sleep-wake cycles.
7. Gonads (ovaries and testicles): located in the pelvis (ovaries) and scrotum (testicles), they produce sex hormones such as estrogen, progesterone, and testosterone that regulate reproductive function and secondary sexual characteristics.
Endocrine gland neoplasms can cause various symptoms depending on the type and location of the tumor. For example, a pituitary gland neoplasm may cause headaches, vision problems, or hormonal imbalances, while an adrenal gland neoplasm may cause high blood pressure, weight gain, or mood changes.
Diagnosis of endocrine gland neoplasms typically involves a combination of medical history, physical examination, imaging studies such as CT or MRI scans, and laboratory tests to measure hormone levels. Treatment options may include surgery, radiation therapy, chemotherapy, or hormonal therapy, depending on the type and stage of the tumor.
Ovarian neoplasms refer to abnormal growths or tumors in the ovary, which can be benign (non-cancerous) or malignant (cancerous). These growths can originate from various cell types within the ovary, including epithelial cells, germ cells, and stromal cells. Ovarian neoplasms are often classified based on their cell type of origin, histological features, and potential for invasive or metastatic behavior.
Epithelial ovarian neoplasms are the most common type and can be further categorized into several subtypes, such as serous, mucinous, endometrioid, clear cell, and Brenner tumors. Some of these epithelial tumors have a higher risk of becoming malignant and spreading to other parts of the body.
Germ cell ovarian neoplasms arise from the cells that give rise to eggs (oocytes) and can include teratomas, dysgerminomas, yolk sac tumors, and embryonal carcinomas. Stromal ovarian neoplasms develop from the connective tissue cells supporting the ovary and can include granulosa cell tumors, thecomas, and fibromas.
It is essential to diagnose and treat ovarian neoplasms promptly, as some malignant forms can be aggressive and potentially life-threatening if not managed appropriately. Regular gynecological exams, imaging studies, and tumor marker tests are often used for early detection and monitoring of ovarian neoplasms. Treatment options may include surgery, chemotherapy, or radiation therapy, depending on the type, stage, and patient's overall health condition.
Aspermia is a medical term that refers to the absence of semen, which is typically released during ejaculation in males. This condition can occur due to various reasons such as obstruction in the reproductive tract, retrograde ejaculation (where semen flows backward into the bladder instead of out through the urethra), or a failure of the testicles to produce sperm. Aspermia is often associated with infertility and requires medical evaluation and treatment.
Pseudomyxoma Peritonei (PMP) is a rare, slow-growing, and invasive cancer that typically starts in the appendix as a low-grade mucinous neoplasm, although it can also arise from other organs of the abdominal cavity. The primary characteristic of PMP is the accumulation of copious amounts of gelatinous ascites (peritoneal fluid containing mucin) within the peritoneal cavity, causing progressive abdominal distension and discomfort.
The condition is classified into three main histological subtypes: disseminated peritoneal adenomucinosis (DPAM), peritoneal mucinous carcinomatosis (PMCA), and hybrid tumors. DPAM is the least aggressive form, while PMCA is more invasive and has a worse prognosis.
The primary treatment for Pseudomyxoma Peritonei involves cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC). This approach aims to remove all visible tumors and destroy any remaining cancer cells within the abdominal cavity. Early diagnosis and aggressive treatment can significantly improve the prognosis for patients with PMP, although long-term survival rates remain variable due to the disease's rarity and heterogeneity.
Salivary gland neoplasms refer to abnormal growths or tumors that develop in the salivary glands. These glands are responsible for producing saliva, which helps in digestion, lubrication of food and maintaining oral health. Salivary gland neoplasms can be benign (non-cancerous) or malignant (cancerous).
Benign neoplasms are slow-growing and typically do not spread to other parts of the body. They may cause symptoms such as swelling, painless lumps, or difficulty swallowing if they grow large enough to put pressure on surrounding tissues.
Malignant neoplasms, on the other hand, can be aggressive and have the potential to invade nearby structures and metastasize (spread) to distant organs. Symptoms of malignant salivary gland neoplasms may include rapid growth, pain, numbness, or paralysis of facial nerves.
Salivary gland neoplasms can occur in any of the major salivary glands (parotid, submandibular, and sublingual glands) or in the minor salivary glands located throughout the mouth and throat. The exact cause of these neoplasms is not fully understood, but risk factors may include exposure to radiation, certain viral infections, and genetic predisposition.
A pancreatic cyst is a fluid-filled sac that forms in the pancreas, a gland located behind the stomach that produces enzymes to help with digestion and hormones to regulate blood sugar levels. Pancreatic cysts can be classified into several types, including congenital (present at birth), retention (formed due to blockage of pancreatic ducts), and pseudocysts (formed as a result of injury or inflammation).
While some pancreatic cysts may not cause any symptoms, others can lead to abdominal pain, bloating, nausea, vomiting, or jaundice. Some cysts may also have the potential to become cancerous over time. Therefore, it is essential to monitor and evaluate pancreatic cysts through imaging tests such as ultrasound, CT scan, or MRI, and in some cases, endoscopic ultrasound (EUS) with fine-needle aspiration (FNA) may be necessary for further evaluation.
Treatment options for pancreatic cysts depend on the type, size, location, and symptoms of the cyst, as well as the patient's overall health condition. Some cysts may require surgical removal, while others can be managed with regular monitoring and follow-up care. It is essential to consult a healthcare provider for proper evaluation and management of pancreatic cysts.
Urologic surgical procedures in males refer to various surgical operations performed on the male urinary system and reproductive organs. These may include:
1. Transurethral Resection of the Prostate (TURP): A procedure used to treat an enlarged prostate, where excess tissue is removed through the urethra using a specialized instrument.
2. Radical Prostatectomy: The surgical removal of the entire prostate gland and some surrounding tissues, usually performed as a treatment for prostate cancer.
3. Cystectomy: Surgical removal of the bladder, often due to bladder cancer. In males, this procedure may also involve removing the prostate and seminal vesicles.
4. Nephrectomy: The surgical removal of a kidney, usually performed due to kidney disease or cancer.
5. Pyeloplasty: A procedure to correct a blockage in the renal pelvis, the part of the kidney where urine collects before flowing into the ureter.
6. Ureterostomy: A surgical procedure that creates an opening from the ureter to the outside of the body, often performed when a portion of the urinary system needs to be bypassed or drained.
7. Orchiectomy: The surgical removal of one or both testicles, often performed as a treatment for testicular cancer.
8. Vasectomy: A minor surgical procedure for male sterilization, where the vas deferens are cut and sealed to prevent sperm from reaching the semen.
9. Testicular Sperm Extraction (TESE): A surgical procedure used to extract sperm directly from the testicles, often performed as part of assisted reproductive techniques for infertile couples.
These procedures may be performed using open surgery, laparoscopy, or robotic-assisted surgery, depending on the specific circumstances and patient factors.
Multiple primary neoplasms refer to the occurrence of more than one primary malignant tumor in an individual, where each tumor is unrelated to the other and originates from separate cells or organs. This differs from metastatic cancer, where a single malignancy spreads to multiple sites in the body. Multiple primary neoplasms can be synchronous (occurring at the same time) or metachronous (occurring at different times). The risk of developing multiple primary neoplasms increases with age and is associated with certain genetic predispositions, environmental factors, and lifestyle choices such as smoking and alcohol consumption.
Retroperitoneal neoplasms refer to abnormal growths or tumors that develop in the retroperitoneal space. This is the area located behind the peritoneum, which is the membrane that lines the abdominal cavity and covers the abdominal organs. The retroperitoneal space contains several vital structures such as the kidneys, adrenal glands, pancreas, aorta, and lymphatic vessels.
Retroperitoneal neoplasms can be benign or malignant (cancerous). Malignant retroperitoneal neoplasms are often aggressive and can invade surrounding tissues and organs, leading to various complications. Common types of retroperitoneal neoplasms include lymphomas, sarcomas, and metastatic tumors from other primary sites. Symptoms may vary depending on the size and location of the tumor but can include abdominal or back pain, weight loss, and swelling in the legs. Diagnosis typically involves imaging studies such as CT scans or MRI, followed by a biopsy to determine the type and grade of the tumor. Treatment options may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.
Minor salivary glands are numerous small exocrine glands that produce saliva and are distributed throughout the oral cavity, nasal cavity, pharynx, larynx, and paranasal sinuses. They are classified as "minor" due to their smaller size compared to the three pairs of major salivary glands (parotid, submandibular, and sublingual). The minor salivary glands are primarily mucous glands, although some contain serous cells. They are responsible for producing approximately 5-10% of the total saliva in the mouth. These glands help moisten the oral cavity, protect the mucosal lining, and facilitate speaking, chewing, and swallowing.
X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.
The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.
CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.
In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.
CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.
In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.
A pancreatic pseudocyst is a fluid-filled sac that forms in the abdomen, usually as a result of pancreatitis or trauma to the pancreas. It is composed of cells and tissues from the pancreas, along with enzymes, debris, and fluids. Unlike true cysts, pseudocysts do not have an epithelial lining. They can vary in size and may cause symptoms such as abdominal pain, nausea, vomiting, or fever. In some cases, they may resolve on their own, but larger or symptomatic pseudocysts may require medical intervention, such as drainage or surgery.
An ovarian cyst is a sac or pouch filled with fluid that forms on the ovary. Ovarian cysts are quite common in women during their childbearing years, and they often cause no symptoms. In most cases, ovarian cysts disappear without treatment over a few months. However, larger or persistent cysts may require medical intervention, including surgical removal.
There are various types of ovarian cysts, such as functional cysts (follicular and corpus luteum cysts), which develop during the menstrual cycle due to hormonal changes, and non-functional cysts (dermoid cysts, endometriomas, and cystadenomas), which can form due to different causes.
While many ovarian cysts are benign, some may have malignant potential or indicate an underlying medical condition like polycystic ovary syndrome (PCOS). Regular gynecological check-ups, including pelvic examinations and ultrasounds, can help detect and monitor ovarian cysts.
Magnetic resonance cholangiopancreatography (MRCP) is a non-invasive medical imaging technique that uses magnetic resonance imaging (MRI) to visualize the bile ducts and pancreatic duct. This diagnostic test does not use radiation like other imaging techniques such as computed tomography (CT) scans or endoscopic retrograde cholangiopancreatography (ERCP).
During an MRCP, the patient lies on a table that slides into the MRI machine. Contrast agents may be used to enhance the visibility of the ducts. The MRI machine uses a strong magnetic field and radio waves to produce detailed images of the internal structures, allowing radiologists to assess any abnormalities or blockages in the bile and pancreatic ducts.
MRCP is often used to diagnose conditions such as gallstones, tumors, inflammation, or strictures in the bile or pancreatic ducts. It can also be used to monitor the effectiveness of treatments for these conditions. However, it does not allow for therapeutic interventions like ERCP, which can remove stones or place stents.
Pancreatic diseases refer to a group of medical conditions that affect the structure and function of the pancreas, a vital organ located in the abdomen. The pancreas has two main functions: an exocrine function, which involves the production of digestive enzymes that help break down food in the small intestine, and an endocrine function, which involves the production of hormones such as insulin and glucagon that regulate blood sugar levels.
Pancreatic diseases can be broadly classified into two categories: inflammatory and non-inflammatory. Inflammatory pancreatic diseases include conditions such as acute pancreatitis, which is characterized by sudden inflammation of the pancreas, and chronic pancreatitis, which is a long-term inflammation that can lead to scarring and loss of function.
Non-inflammatory pancreatic diseases include conditions such as pancreatic cancer, which is a malignant tumor that can arise from the cells of the pancreas, and benign tumors such as cysts or adenomas. Other non-inflammatory conditions include pancreatic insufficiency, which can occur when the pancreas does not produce enough digestive enzymes, and diabetes mellitus, which can result from impaired insulin production or action.
Overall, pancreatic diseases can have serious consequences on a person's health and quality of life, and early diagnosis and treatment are essential for optimal outcomes.
Extrahepatic bile ducts refer to the portion of the biliary system that lies outside the liver. The biliary system is responsible for producing, storing, and transporting bile, a digestive fluid produced by the liver.
The extrahepatic bile ducts include:
1. The common hepatic duct: This duct is formed by the union of the right and left hepatic ducts, which drain bile from the corresponding lobes of the liver.
2. The cystic duct: This short duct connects the gallbladder to the common hepatic duct, allowing bile to flow into the gallbladder for storage and concentration.
3. The common bile duct: This is the result of the fusion of the common hepatic duct and the cystic duct. It transports bile from the liver and gallbladder to the duodenum, the first part of the small intestine, where it aids in fat digestion.
4. The ampulla of Vater (or hepatopancreatic ampulla): This is a dilated area where the common bile duct and the pancreatic duct join and empty their contents into the duodenum through a shared opening called the major duodenal papilla.
Extrahepatic bile ducts can be affected by various conditions, such as gallstones, inflammation (cholangitis), strictures, or tumors, which may require medical or surgical intervention.
An appendectomy is a surgical procedure in which the vermiform appendix is removed. This procedure is performed when a patient has appendicitis, which is an inflammation of the appendix that can lead to serious complications such as peritonitis or sepsis if not treated promptly. The surgery can be done as an open procedure, in which a single incision is made in the lower right abdomen, or as a laparoscopic procedure, in which several small incisions are made and specialized instruments are used to remove the appendix. In some cases, if the appendix has burst, a more extensive surgery may be required to clean out the abdominal cavity.
A pancreatectomy is a surgical procedure in which all or part of the pancreas is removed. There are several types of pancreatectomies, including:
* **Total pancreatectomy:** Removal of the entire pancreas, as well as the spleen and nearby lymph nodes. This type of pancreatectomy is usually done for patients with cancer that has spread throughout the pancreas or for those who have had multiple surgeries to remove pancreatic tumors.
* **Distal pancreatectomy:** Removal of the body and tail of the pancreas, as well as nearby lymph nodes. This type of pancreatectomy is often done for patients with tumors in the body or tail of the pancreas.
* **Partial (or segmental) pancreatectomy:** Removal of a portion of the head or body of the pancreas, as well as nearby lymph nodes. This type of pancreatectomy is often done for patients with tumors in the head or body of the pancreas that can be removed without removing the entire organ.
* **Pylorus-preserving pancreaticoduodenectomy (PPPD):** A type of surgery used to treat tumors in the head of the pancreas, as well as other conditions such as chronic pancreatitis. In this procedure, the head of the pancreas, duodenum, gallbladder, and bile duct are removed, but the stomach and lower portion of the esophagus (pylorus) are left in place.
After a pancreatectomy, patients may experience problems with digestion and blood sugar regulation, as the pancreas plays an important role in these functions. Patients may need to take enzyme supplements to help with digestion and may require insulin therapy to manage their blood sugar levels.
Cystadenocarcinoma, serous is a type of cystic tumor that arises from the lining of the abdominal or pelvic cavity (the peritoneum). It is called "serous" because the tumor cells produce a thin, watery fluid similar to serum.
Cystadenocarcinoma is a malignant (cancerous) tumor that can invade surrounding tissues and spread (metastasize) to other parts of the body. It typically affects women over the age of 50 and can cause symptoms such as abdominal pain, bloating, and changes in bowel or bladder habits.
Serous cystadenocarcinoma is a subtype of ovarian cancer that arises from the surface of the ovary. It can also occur in other organs, including the fallopian tubes, peritoneum, and endometrium. This type of tumor tends to grow slowly but can spread widely throughout the abdominal cavity, making it difficult to treat.
Treatment for serous cystadenocarcinoma typically involves surgery to remove the tumor and any affected tissues, followed by chemotherapy to kill any remaining cancer cells. The prognosis for this type of cancer depends on several factors, including the stage of the disease at diagnosis, the patient's age and overall health, and the response to treatment.
Adenocarcinoma, mucinous is a type of cancer that begins in the glandular cells that line certain organs and produce mucin, a substance that lubricates and protects tissues. This type of cancer is characterized by the presence of abundant pools of mucin within the tumor. It typically develops in organs such as the colon, rectum, lungs, pancreas, and ovaries.
Mucinous adenocarcinomas tend to have a distinct appearance under the microscope, with large pools of mucin pushing aside the cancer cells. They may also have a different clinical behavior compared to other types of adenocarcinomas, such as being more aggressive or having a worse prognosis in some cases.
It is important to note that while a diagnosis of adenocarcinoma, mucinous can be serious, the prognosis and treatment options may vary depending on several factors, including the location of the cancer, the stage at which it was diagnosed, and the individual's overall health.
Serous cystadenoma
Pancreatic serous cystadenoma
Ovarian serous cystadenoma
Ovary
Papillary serous cystadenocarcinoma
Surgical Outcomes Analysis and Research
Pancreatic mucinous cystic neoplasm
Cystadenocarcinoma
Intraductal papillary mucinous neoplasm
Ovarian cyst
Ovarian cystadenoma
Mucinous cystadenoma
Solid pseudopapillary tumour
Pancreatic mucinous cystadenoma
Cystadenoma
Serous cystadenocarcinoma
List of MeSH codes (C04)
Pancreatectomy
Von Hippel-Lindau disease
Pancreatic disease
Psammoma body
Cystic lesions of the pancreas
Zeynel Mungan
Ovarian cancer
International Classification of Diseases for Oncology
Serous cystadenoma - Wikipedia
Pancreatic Serous Cystadenoma Imaging: Practice Essentials, Computed Tomography, Magnetic Resonance Imaging
Pancreatic Serous Cystadenoma | SeekHealthZ
Pages that link to "Serous cystadenoma" - Libre Pathology
Humongous Ovarian Serous Cystadenoma in a Postmenopausal Woman | Scitechnol
An unusual presentation of pancreatic serous cystadenoma | International Surgery Journal
A Postmenopausal Woman with Giant Ovarian Serous Cyst Adenoma - MediHelp
Case report Solid variant of serous cystadenoma of the pancreas
A giant serous ovarian cystadenoma in a young teenager patient - BosnianPathology
Adrenal Ectopia Within the Wall of an Ovarian Serous Cystadenoma - Balkan Medical Journal
Comparison of immunohistochemical characteristics of endometriomas with non-endometriotic benign ovarian cysts
High concentrations of inhibin A and inhibin B in ovarian serous cystadenoma: Relationship with oestradiol and nitric oxide...
EP729 A rare form of ovarian serous cystadenoma with monodermal teratoma in a 53 year old patient | International Journal of...
Testicular Cancer - EPIDEMIOLOGY AETIOLOGY PATHOLOGY - Uroweb
Pelvic Masses Including Ovary, Tube and Uterus
Pg Blazer - Online Test Series 17 - Obstetrics & Gynaecology - ProProfs Quiz
Unique Presentation of Giant Metastatic Microcystic Serous Adenocarcinoma of the Pancreas
Ovarian cystadenoma - Wikipedia
Omniscan (gadodiamide) dosing, indications, interactions, adverse effects, and more
Benign Lesions of the Ovaries: Dysfunctional Ovarian Cysts, Benign Epithelial Neoplastic Ovarian Cysts, Benign Solid Ovarian...
Pancreatic disorders | PPT
K Deodhar | West Indian Medical Journal
US Quiz of the Month - April 2019 - Sociedade Portuguesa de Gastrenterologia
US Quiz of the Month - Outubro 2022 - Sociedade Portuguesa de Gastrenterologia
Priv.-Doz. Dr. med. Formentini | Universitätsklinikum Ulm
Pankreasın Kistik Lezyonlarında Endoskopik Ultrasonografinin Rolü | Article | Türkiye Klinikleri
Human Benign Reproductive system | UTE02 | Pantomics
2014 ICD-9-CM Diagnosis Codes 220.* : Benign neoplasm of ovary
Baby’s Pregnancy Calendar
Tumors11
- Because of significant overlap in the imaging findings of mucinous and serous pancreatic tumors, these tumors should be followed up with surveillance CT scanning to assess interval growth if aspiration is not performed. (medscape.com)
- Serous tumors secrete serous fluids and are originated by invagination of the surface epithelium of ovary. (medihelp.life)
- Tumors of the pancreas that contain substantial cystic components include mainly mucinous cystic neoplasm, intraductal papillary mucinous neoplasm, solid pseudopapillary tumor, and cystadenomas (which encompass microcystic, macrocystic/oligocystic, and rare solid serous adenomas). (hindawi.com)
- Pancreatic cystic tumors fall into the serous or mucinous category. (hindawi.com)
- One third of all ovarian tumors are serous, and two thirds of these serous tumors are benign. (medscape.com)
- By definition, serous tumors are characterized by a proliferation of epithelium resembling that lining the fallopian tubes. (medscape.com)
- Serous cystadenoma (SCA) is a relatively rare pancreatic neoplasm which accounts for only 2% of pancreatic tumors (1-3). (spg.pt)
- The specific binding of hFSH were demonstrated in three tumors of epithelial origin (serous cystadenoma and mucinous cystadenoma) and in two of sex cord-stromal origin (theca cell tumor and granulosa cell tumor). (nii.ac.jp)
- Serous tumors occur most commonly in the ovaries and rarely in the para tubal region. (ikppress.org)
- Large tumors of serous cystic adenomas in the pancreatic body-to-tail severely compress the surrounding organs and retroperitoneal space. (springeropen.com)
- Guidelines, concerning pancreatic cystic tumors indicate the management with mucinous, serous cystic pancreatic neoplasms and solid pseudopappilary tumor, while the management with pancreatic cystic neuroendocrine tumors is not included into these standards. (viamedica.pl)
Neoplasm7
- The 2 most common cystic neoplasms of the pancreas are serous cystadenoma and mucinous cystic neoplasm. (medscape.com)
- The important point to remember is that serous cystadenoma is benign, whereas the biologic behavior of the mucinous cystic neoplasm and the IPMT ranges from benign to malignant. (medscape.com)
- A pancreatic serous cystadenoma is a benign glycogen-rich serous epithelial pancreatic neoplasm that can occur anywhere in the pancreas and is typically encountered in elderly women. (seekhealthz.com)
- A case of duodenal hemorrhage due to arteriorvenous malformation around a serous cystic neoplasm. (ijsurgery.com)
- Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the Internstional Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumours of the Pancreas). (ijsurgery.com)
- According to the WHO classification, SCNs are classified into microcystic SCA, macrocystic SCA, solid serous adenoma, von Hippel-Lindau-associated serous cyst neoplasm, and mixed serous-neuroendocrine neoplasm (2). (spg.pt)
- Microcystic serous cystadenoma mimicking pancreatic neuroendocrine neoplasm: report of a resected case with preoperative diagnostic difficulty and review of the literature. (spg.pt)
Ovary5
- Serous cystadenoma may refer to: Ovarian serous cystadenoma, a very common benign tumour of the ovary Pancreatic serous cystadenoma, also known as serous microcystic adenoma This article includes a list of related items that share the same name (or similar names). (wikipedia.org)
- On histopathological examination, the cyst was confirmed as benign serous cystadenoma of the ovary. (medihelp.life)
- The histopathology was suggestive of benign serous cystadenoma of the ovary. (medihelp.life)
- Results The histology of the ovary showed a large serous cystadenoma (size 8.5 × 5.5 cm). (bmj.com)
- Ovarian cystadenoma is a cystic benign tumor of the ovary. (wikipedia.org)
Neoplasms8
- Serous cystadenomas are more common than mucinous cystic neoplasms, at a ratio of about 2:1. (medscape.com)
- Risk of malignancy in serous cystic neoplasms of the pancreas. (ijsurgery.com)
- Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment. (ijsurgery.com)
- Tseng JF, Warshaw AL, Sahani DV, Lauwers GY, Rattner DW, Fernandez-del Castillo C. Serous cystic neoplasms of the pancreas: tumour growth rates and recommendations for treatment. (ijsurgery.com)
- Tumour size and location correlate with behavior is pancreatic serous cystic neoplasms. (ijsurgery.com)
- Two types are recognized: serous and mucinous.Ovarian cystadenomas are common benign epithelial neoplasms that carry an excellent prognosis. (wikipedia.org)
- Cystic neoplasms are rare in this site, and bilateral serous neoplasms in this site have not yet been reported. (ikppress.org)
- Sp17 is highly expressed in benign, borderline, and low grade malignant serous ovarian neoplasms and can be quantified in serum. (biomedcentral.com)
Cystadenomas6
- Pancreatic serous cystadenomas are commonly found in women 60 years of age or older (approximately 75% of cases). (medscape.com)
- [ 7 ] These lesions are generally small (mean diameter, 31 mm), but giant pancreatic serous cystadenomas (≥10 cm) have been reported. (medscape.com)
- surgery is generally indicated only for large serous cystadenomas. (medscape.com)
- Serous cystadenomas follow a benign and asymptomatic course and do not present a significant size change during follow up. (ijsurgery.com)
- The present study evaluated the concentrations of inhibin A and inhibin B and the relationship with oestradiol and nitric oxide metabolites in fluid collected from benign ovarian serous cystadenomas (n = 15). (uniud.it)
- High concentrations of inhibin A (median = 89.3 ng/ml) and inhibin B (median = 116.1 ng/ml) were found in the cystic fluid of ovarian serous cystadenomas. (uniud.it)
Cystadenocarcinoma1
- Features on computed tomography raised the possibility of biliary cystadenoma or cystadenocarcinoma. (uwi.edu)
Study of 2622 patients1
- In a study of 2622 patients with serous cystadenoma, 74% were women, with a mean age of 58 years. (medscape.com)
Pancreas2
- We describe a case of a solid variant of serous cystadenoma of the pancreas. (archivesofmedicalscience.com)
- Solid variant of serous cystadenoma of the pancreas is difficult to diagnose preoperatively. (archivesofmedicalscience.com)
Microcystic2
Histopathological2
- Histopathological evaluation of mass suggested a benign serous cystadenoma. (scitechnol.com)
- The tumour was diagnosed as a solid variant of serous cystadenoma by histopathological examination. (archivesofmedicalscience.com)
Suggestive1
- Findings from plain radiography and upper GI series are nondiagnostic, except the finding of a classic sunburst central calcification, which is suggestive of a serous cystadenoma. (medscape.com)
Histopathology2
- She underwent a liver resection, and histopathology confirmed a serous biliary cystadenoma. (uwi.edu)
- Histopathology revealed a bilateral para tubalserous cystadenoma. (ikppress.org)
Adenoma1
- In rare cases, however, the cysts are so small and crammed together that it presents as a pseudo solid-appearing serous cystic adenoma (1). (spg.pt)
Teratoma1
- We present an interesting case of ovarian serous cystadenoma with monodermal teratoma, without clinical or biochemical features of hyperthyroidism, as well as the therapeutic approach. (bmj.com)
Epithelium3
- Serous cubic epithelium was lining the inner portion of the cyst. (balkanmedicaljournal.org)
- Low-grade serous is a type of ovarian cancer that starts in the thin layer of tissue around the ovaries (also known as the epithelium). (letstalkaboutlgsoc.com)
- Serous means that the cancer started in the serous membrane, which is part of the epithelium. (letstalkaboutlgsoc.com)
Cysts3
- Large/giant ovarian cysts are benign in most of the cases and histopathologically these cysts are either serous or mucinous [4]. (medihelp.life)
- MRI revealed a cystic lesion with multiple millimetric cysts separated by filiform septations with mild wall enhancement and no restricted diffusion, establishing a diagnosis of serous cystadenoma. (spg.pt)
- Simple serous cysts / fimbrial cysts are the most common cystic lesions found in the para ovarian region. (ikppress.org)
Malignant1
- Inhibin production has been demonstrated in malignant epithelial ovarian tumours, but secretion of inhibins by benign cystadenoma has not yet been reported. (uniud.it)
Fluid2
- The cyst was filled with clear serous fluid. (medihelp.life)
- The cyst which was removed surgically, was filled with serous fluid and there was a 0.2 cm yellowish nodule within the wall. (balkanmedicaljournal.org)
Presentation1
- Hamid M, Tbouda M, Majbar AM, Raiss M, Ahallat M. Pancreatic solid serous cystadenoma treated by laparoscopy: Presentation of a new case report and review of the literature. (spg.pt)
Unusual1
- Hence we report an unusual case of bilateral serous cystadenoma of a para tubal region. (ikppress.org)
Rarely1
- compared with the serous variety, they rarely are associated with true papillae. (medscape.com)
Patients2
- Twenty patients with the diagnosis of endometrioma and 30 control subjects consisting of ovarian serous cystadenoma (n=10), ovarian mucinous cystadenoma (n=10) and normal ovarian tissue (n=10) were included. (nih.gov)
- Serum concentrations were higher in patients with Sp17 tissue expression, and the highest concentrations were noted among patients with serous and clear cell adenocarcinomas. (biomedcentral.com)
Diagnosis2
- Yang KS, O'Shea A, Zelga P, Liss AS, Del Castillo CF, Weissleder R. Extracellular vesicle analysis of plasma allows differential diagnosis of atypical pancreatic serous cystadenoma. (harvard.edu)
- How common is a diagnosis of low-grade serous ovarian cancer? (letstalkaboutlgsoc.com)
Rare1
- Low-grade serous ovarian cancer (also known as LGSOC) is a rare type of cancer. (letstalkaboutlgsoc.com)
Common1
- It is distinct from the more common high-grade serous ovarian cancer (also known as HGSOC) and grows and spreads more slowly. (letstalkaboutlgsoc.com)